Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study

• WAKABAYASHI Hiroki

  Department of Orthopaedic Surgery, Mie University Graduate School of Medicine

• HASEGAWA Masahiro

  Department of Orthopaedic Surgery, Mie University Graduate School of Medicine

• NISHIOKA Yosuke

  Clinical Research Institute for Rheumatic Disease

• SUDO Akihiro

  Department of Orthopaedic Surgery, Mie University Graduate School of Medicine

• NISHIOKA Kusuki

  Institute of Medical Science, Tokyo Medical University

Journal

• Modern rheumatology

  Modern rheumatology 22 (1), 116-121, 2012-02-01

Keywords

• Rheumatoid arthritis
• Tumor necrosis factor inhibitors
• Interleukin-6
• Tocilizumab
• Etanercept

Details

• CRID: 1573950400513776256
• NII Article ID: 10030207090
• NII Book ID: AA1157187X
• ISSN: 14397595
• Text Lang: en
• Data Source:
  • CiNii Articles